Confirmation of the ε4 allele of the apolipoprotein e gene as a risk factor for late–onset alzheimer's disease

Neurology

Volumn 44, Issue 2, 1994, Pages 342-344

  Brousseau, T ^a   Legrain, S ^a   Berr, C ^a   Gourlet, V ^a   Vidal, O ^a   Amouyel, P ^a  

^a Institut Pasteur de Lille ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGE; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; FEMALE; GENETICS; GENOTYPE; HUMAN; MALE; ONSET AGE; REFERENCE VALUE; RISK FACTOR; CHROMOSOME 19; CLINICAL ARTICLE; CONTROLLED STUDY; GENE LOCUS; GENETIC POLYMORPHISM; HUMAN TISSUE; PRIORITY JOURNAL;

AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; FEMALE; GENOTYPE; HUMAN; MALE; REFERENCE VALUES; RISK FACTORS;

EID: 0028167193     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.44.2.342     Document Type: Article

References (10)

1. Pericak-Vance MA, Bebout JL, Gaskell PC Jr, et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991;48:1034-1050.
2. Boyles JK, Zoellner CD, Anderson LJ, et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J Clin Invest 1989;83:1015-1031.
3. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to 3-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981.
4. Wisniewski T, Golabek A, Matsubara E, Ghiso J, Frangione B. Apolipoprotein E: binding to soluble Alzheimer’s 3-amyloid. Biochem Biophys Res Commun 1993;192:359-365.
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed, rev. Washington, DC: American Psychiatric Association Press, 1987.
6. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
7. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31:545-548.
8. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
9. Wasco W, Brook JD, Tanzi RE. The amyloid precursor-like protein (APLP) gene maps to the long arm of human chromosome 19. Genomics 1993;15:237-239.
10. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991;541:163-166.